Skip to navigation menu Skip to content
Informational Alert

Due to a measles case in the community, please call before coming to Seattle Children’s if you or your child has potential measles symptoms.

High Priority Alert

Masking and Visitation Changes: Due to high rates of respiratory illnesses in our community, we’ve made changes to our masking and visitation guidelines .

Illustration of a calendarIllustration of a document pageIllustration of a heart over a handIllustration of an envelopeIllustration of the letter i inside a circleIllustration of a map markerIllustration of a caduceusIllustration of a user with a plus signIllustration of a telephoneIllustration of a question mark inside a circleIllustration of a video cameraDocument with a PDF label
Current Research Studies

Observational Study for Pediatric Rheumatic Diseases: The CARRA Registry

CARRA_Registry

What is the goal of the study?

The Childhood Arthritis and Rheumatology Research Alliance (CARRA) Registry is an international registry of children and young adults with pediatric-onset rheumatic conditions such as juvenile idiopathic arthritis (JIA). The CARRA Registry is generating valuable data on the epidemiology, disease outcomes and medication safety among children with diverse pediatric rheumatologist diseases. The Registry also intends to follow each participant for at least 10 years to help understand disease outcomes and how they may change over time. Some participants are also eligible for participation in sub-studies, which address more specific questions, and for biospecimen collection, to better understand the biology of these diseases. The CARRA Registry aims to make it possible for all affected children in North America to have the opportunity to participate in meaningful and high-quality clinical and translational research.

Who can participate in the study?

This study is a good fit for children and families who are interested in participating in research and learning more about their disease. Please ask your pediatric rheumatologist for more details about eligibility.

Study Team: